diclazuril Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

diclazuril

huvepharma eood - diclazuril - unknown - diclazuril ungrouped active 0.0 - active constituent

Toltrazuril Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

toltrazuril

alleva animal health ltd - toltrazuril - unknown - toltrazuril antiprotozoal-coccidiostat active 0.0 - active constituent

PONAZURIL powder Egyesült Államok - angol - NLM (National Library of Medicine)

ponazuril powder

willow birch pharma, inc. - ponazuril (unii: jpw84as66u) (ponazuril - unii:jpw84as66u) -

DICLAZURIL powder Egyesült Államok - angol - NLM (National Library of Medicine)

diclazuril powder

darmerica, llc - diclazuril (unii: k110k1b1ve) (diclazuril - unii:k110k1b1ve) -

DICLAZURIL JANSSEN 2.5 MG/ML ORAL SUSPENSION Írország - angol - HPRA (Health Products Regulatory Authority)

diclazuril janssen 2.5 mg/ml oral suspension

janssen cilag ltd. - diclazuril - oral suspension - 2.5 mg/ml - bovine - coccidiostats

TP-DICOCCI SOL Diclazuril 0.5% wv Solution Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

tp-dicocci sol diclazuril 0.5% wv solution

thye pharma sdn. bhd - diclazuril -

PF DICLAZURIL PREMIX 0.5% WW POWDER Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pf diclazuril premix 0.5% ww powder

panfast marketing (m) sdn bhd - diclazuril -

Forceris (Toltrazuril 30mgml + Iron 133mgml) Suspension for injection Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

forceris (toltrazuril 30mgml + iron 133mgml) suspension for injection

ceva animal health malaysia sdn. bhd. - toltrazuril; gleptoferron -

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).